FDA - Spark Newswire

3 minute read

AstraZeneca Announced Koselugo Approved in the EU for Children with NF1

Today, 12:45 PM

AstraZeneca (NYSE: AZN) and MSD's (NYSE: MRK) Koselugo (selumetinib) has been granted conditional approval in the European Union (EU) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in paediatric patients with neurofibromatosis type 1 (

AZN

2 minute read

FDA
News

Moleculin Biotech 8-K Shows Co. Entered Amendment To Patent, Technology License Deal With University Of Texas

By Benzinga Newsdesk

Today, 12:45 PM

On June 15, 2021, Moleculin Biotech, Inc. (the “Company”) entered into an amendment no. 4 (the “Amendment 4”) to the Patent and Technology License Agreement dated April 2, 2012 entered into by and

MBRX

1 minute read

Cassava Sciences Says Selects Premier Research International For Phase 3 Clinical Program In Alzheimer’s Disease

By Benzinga Newsdesk

Today, 12:45 PM

Cassava Sciences, Inc. (NASDAQ:SAVA), a biotechnology company focused on Alzheimer's disease, today announced the selection of Premier Research International as its clinical research organization (CRO) to help

SAVA

2 minute read

Inhibrx Says Initiates Potential Registration-Enabling Phase 2 Study Of INBRX-109 In Conventional Chondrosarcoma Patients; Says Updates Data For Ongoing Phase 1 Study; Announces Amended Loan Agreement With Oxford

By Benzinga Newsdesk

Today, 12:45 PM

Inhibrx, Inc. (NASDAQ:INBX), a biotechnology company with four clinical programs in development, announced initiation of a potential registration-enabling Phase 2 study of INBRX-109 in conventional

INBX

1 minute read

Ocugen Shares Up 9% Following Earlier Report ‘Bharat Biotech submitted Phase 3 clinical trials data of COVAXIN to Drugs Controller General of India (DCGI) over the weekend: Govt sources’

By Benzinga Newsdesk

Today, 12:45 PM

https://twitter.com/ANI/status/1407012119095087106?s=20

OCGN

1 minute read

FDA
News

UPDATE: Who Epidemiologist Says There Might Be In Future A ‘Constellation Of Mutations’ That Means Vaccines Lose Their Potency

By Benzinga Newsdesk

Today, 12:45 PM

-Reuters

SPY

1 minute read

FDA
News

WHO Epidemiologist Says Seeing Some Reduced Efficacy Of Vaccines Against Delta Coronavirus Variant, But They Are Still Effective At Preventing Severe Disease And Death

By Benzinga Newsdesk

Today, 12:45 PM

-Reuters

SPY

1 minute read

Medtronic Scores FDA Expanded Approval For Cardiac Cryoablation Catheters For Paroxysmal Atrial Fibrillation

By Vandana Singh

Today, 12:45 PM

The FDA has granted expanded approval for Medtronic plc’s (NYSE:MDT) cardiac cryoablation catheters for atrial fibrillation. The approval comes for Arctic Front…

MDT

1 minute read

Masimo’s Wearable Thermometer Scores FDA Approval For Prescription, OTC Use

By Vandana Singh

Today, 12:45 PM

Masimo (NASDAQ:MASI) has announced that Radius Tº, a wearable, wireless thermometer, has received FDA 510(k) clearance for both prescription and over-the-counter…

MASI

1 minute read

Agios Pharma Files US Application For Mitapivat In PK Deficiency

By Vandana Singh

Today, 12:45 PM

Agios Pharmaceuticals Inc (NASDAQ:AGIO) has submitted an FDA marketing application seeking approval for mitapivat to treat adults with pyruvate kinase (PK)…

AGIO